Comparison of health-related quality of life measures in chronic obstructive pulmonary disease

Health and Quality of Life Outcomes

Todd A Lee¹  Yoojung Yang²  A Simon Pickard² 

[1] Center for Management of Complex Chronic Care, Hines Veterans Affairs Hospital, Hines, Illinois, 60141, USA;Center for Pharmacoeconomic Research and Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL, 60612, USA

关键词: EQ-5D;    health status;    COPD;    quality of life;    respiratory disease;   

Others  :  826756
DOI  :  10.1186/1477-7525-9-26

 received in 2011-02-14, accepted in 2011-04-18,  发布年份 2011

【 摘 要 】

Background

The aims of this study were: (1) to compare the discriminative ability of a disease-specific instrument, the St. George's Respiratory Questionnaire (SGRQ) to generic instruments (i.e., EQ-5D and SF-36); and (2), to evaluate the strength of associations among clinical and health-related quality of life (HRQL) measures in chronic obstructive pulmonary disease (COPD).

Methods

We analyzed data collected from 120 COPD patients in a Veterans Affairs hospital. Patients self-completed two generic HRQL measures (EQ-5D and SF-36) and the disease-specific SGRQ. The ability of the summary scores of these HRQL measures to discriminate COPD disease severity based on Global Obstructive Lung Disease (GOLD) stage was assessed using relative efficiency ratios (REs). Strength of correlation was used to further evaluate associations between clinical and HRQL measures.

Results

Mean total scores for PCS-36, EQ-VAS and SGRQ were significantly lower for the more severe stages of COPD (p < 0.05). Using SGRQ total score as reference, the summary scores of the generic measures (PCS-36, MCS-36, EQ index, and EQ-VAS) all had REs of <1. SGRQ exhibited a stronger correlation with clinical measures than the generic summary scores. For instance, SGRQ was moderately correlated with FEV₁ (r = 0.43), while generic summary scores had trivial levels of correlation with FEV₁ (r < 0.2).

Conclusions

The SGRQ demonstrated greater ability to discriminate among different levels of severity stages of COPD than generic measures of health, suggestive that SGRQ may provide COPD studies with greater statistical power than EQ-5D and SF-36 summary scores to capture meaningful differences in clinical severity.

【 授权许可】

   
2011 Pickard et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]World Health Organization: Chronic obstructive pulmonary disease. [http://www.who.int/mediacentre/factsheets/fs315/en/index.html] webcite Accessed February 10, 2011
• [2]Global Initiative for Chronic Obstructive Lung Disease: Global strategy for diagnosis, management, and prevention of COPD (updated 2010). [http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=1116] webcite Accessed February 10, 2011
• [3]Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T: A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999, 116(6):1632-1637.
• [4]Menn P, Weber N, Holle R: Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ. Health and quality of life outcomes 8:39.
• [5]Stahl E, Lindberg A, Jansson SA, Ronmark E, Svensson K, Andersson F, Lofdahl CG, Lundback B: Health-related quality of life is related to COPD disease severity. Health and quality of life outcomes 2005, 3:56. BioMed Central Full Text
• [6]Stavem K: Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease. Qual Life Res 1999, 8(1-2):45-54.
• [7]Alonso J, Prieto L, Ferrer M, Vilagut G, Broquetas J, Roca J, Batlle J, Antó J: Testing the measurement properties of the Spanish version of the SF-36 Health Survey among male patients with chronic obstructive pulmonary disease. Quality of Life in COPD Study Group. J Clin Epidemiol 1998, 51:1087-1094.
• [8]Tsukino M, Nishimura K, Ikeda A, Koyama H, Mishima M, Izumi T: Physiologic factors that determine the health-related quality of life in patients with COPD. Chest 1996, 110:896-903.
• [9]Hesselink A, van der Windt D, Penninx B, Wijnhoven H, Twisk J, Bouter L, van Eijk J: What predicts change in pulmonary function and quality of life in asthma or COPD? J Asthma 2006, 43:513-519.
• [10]Wijnhoven HAH, Kriegsman DMW, Hesselink AE, Penninx BWJH, de Haan M: Determinants of different dimensions of disease severity in asthma and COPD. Chest 2001, 119(4):1034-1042.
• [11]Jones PW, Quirk FH, Baveystock CM: The St George's Respiratory Questionnaire. Respir Med 1991, 85(Suppl B):25-31. discussion 23-27
• [12]Brooks R, Rabin R, Charro F, (eds): The measurement and valuation of health status using EQ-5D: a European perspective. Dordrecht: Kluwer Academic Publishers; 2003.
• [13]Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): I. conceptual framework and item selection. Medical care 1992, 30(6):473-483.
• [14]Katsura H, Yamada K, Kida K: Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease. Journal of the American Geriatrics Society 2003, 51(8):1131-1135.
• [15]Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA: Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respiratory Medicine 2008, 102(4):519-536.
• [16]Szende A, Svensson K, Stahl E, Meszaros A, Berta G: Psychometric and utility-based measures of health status of asthmatic patients with different disease control level. PharmacoEconomics 2004, 22(8):537-547.
• [17]Joo MJ, Lee TA, Bartle B, van de Graaff WB, Weiss KB: Patterns of healthcare utilization by COPD severity: a pilot study. Lung 2008, 186(5):307-312.
• [18]Celli B, MacNee W: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-46.
• [19]Lung function testing: selection of reference values and interpretative strategies Am Rev Respir Dis 1991, 144:1202-1218.
• [20]Borg GA: Psychophysical bases of perceived exertion. Medicine and science in sports and exercise 1982, 14(5):377-381.
• [21]Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
• [22]Kazis LE, Ren XS, Lee A, Skinner K, Rogers W, Clark J, Miller DR: Health status in VA patients: results from the Veterans Health Study. American Journal of Medical Quality 1999, 14(1):28-38.
• [23]Kazis LE, Miller DR, Clark JA, Skinner KM, Lee A, Ren XS, Spiro A, Rogers WH, Ware JE Jr: Improving the response choices on the veterans SF-36 health survey role functioning scales: results from the Veterans Health Study. The Journal of ambulatory care management 2004, 27(3):263-280.
• [24]Dolan P: Modeling valuations for EuroQol health states. Medical care 1997, 35(11):1095-1108.
• [25]Shaw JW, Johnson JA, Coons SJ: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Medical care 2005, 43(3):203-220.
• [26]Hays R, Anderson R, Revicki D: Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993, 2:441-449.
• [27]Juniper E, Guyatt G, Jaeschke R: Chapter 6: How to develop and validate a new health-related quality of life instrument. In Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd edition. Edited by Spilker B. Philadelphia: Lippincott-Raven Publishers; 1996:49-56.
• [28]de Vries M, Ouwendijk R, Kessels AG, de Haan MW, Flobbe K, Hunink MGM, van Engelshoven JMA, Nelemans PJ: Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease. Journal of Vascular Surgery 2005, 41(2):261-268.
• [29]Krahn M, Bremner K, Tomlinson G, Ritvo P, Irvine J, Naglie G: Responsiveness of disease-specific and generic utility instruments in prostate cancer patients. Quality of Life Research 2007, 16(3):509-522.
• [30]Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH: A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science & Medicine 2005, 60(7):1571-1582.
• [31]Pickard AS, Neary MP, Cella D: Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health and quality of life outcomes 2007, 5:70. BioMed Central Full Text